New mRNA Flu Vaccine for Adults 50+: 4 Essential Facts Before Your Shot

This fall, adults 50 and older can choose a new mRNA flu vaccine for the first time. The FDA approved Moderna’s mFLUSIVA in August 2026, and in a trial of more than 40,000 adults 50+, it lowered the relative risk of flu illness by about 27% compared with a standard-dose shot. Here is what you need to know before your appointment.

Why the mRNA Flu Vaccine Matters to You

Flu is not a minor nuisance after 50. The CDC estimates flu causes 120,000 to 710,000 hospitalizations and 6,300 to 52,000 deaths in the U.S. each year, and older adults carry much of that risk.

Having another effective option means more choice at the pharmacy counter. It can also help if your usual vaccine is out of stock.

The mRNA flu vaccine was tested specifically in adults 50 and older, including many people more likely to face serious flu complications, such as those with heart disease, diabetes, or lung conditions. That is why its approval is limited to this age group for now.

Key Facts About mFLUSIVA

According to UT Southwestern Medical Center, the vaccine delivers mRNA instructions that help your cells briefly make a harmless flu protein. Your immune system learns to recognize it and builds antibodies.

• Who can get it: Adults 50 and older only, for now.
• How well it worked: 2% of trial participants who got mFLUSIVA developed flu, versus 2.8% with a standard-dose shot.
• What is not in it: No whole flu virus, egg protein, antibiotics, or preservatives. It cannot give you the flu or change your DNA.
• Side effects: About 75% reported at least one short-term reaction, compared with 47% for the standard shot. Most were mild and lasted about two days.

Common reactions include arm soreness, tiredness, headache, muscle aches, chills, and underarm tenderness.

What This Means for You

For adults 50 to 64, the CDC does not prefer one approved flu vaccine over another. At 65+, the CDC has historically recommended high-dose, recombinant, or adjuvanted shots, and mFLUSIVA is now approved for this group too.

Which flu shot should you choose?

Ask your doctor or pharmacist to compare options based on your health history and past reactions. If you want the mildest experience, mention that the mRNA shot had more short-term side effects in trials. If your preferred vaccine is unavailable, choose another age-appropriate one. Getting vaccinated matters most.

When is the best time to get vaccinated?

Your body needs about two weeks to build protection. Experts generally suggest getting your shot in September or October, with October ideal for many higher-risk adults. Don’t wait for local case counts to climb, because those reports lag behind the spread.

What other fall vaccines should you ask about?

Many older adults also benefit from an updated COVID-19 shot, an RSV vaccine (recommended for everyone 75+ and higher-risk adults 50 to 74), and a pneumococcal vaccine. Most can be given in a single visit. Our preventive care checklist for adults over 50 can help you plan the rest of your fall appointments.

How does it compare with traditional flu shots?

Traditional flu shots contain an inactivated virus or purified viral proteins, and some are grown in eggs. The mRNA flu vaccine instead carries three mRNA sequences inside tiny fat-based particles. The mRNA breaks down naturally after it delivers its instructions. Both approaches aim for the same result: antibodies that help you fight off a matching flu strain faster.

Looking Forward

Because mRNA vaccines are faster to update, researchers hope future flu shots can keep pace with changing strains more quickly. For now, the best step is simple: pick an age-appropriate vaccine and get it this fall.

Stay current on other outbreaks with our guide to how adults over 50 can stay protected from measles, and review coverage changes in your Medicare Annual Notice of Change before open enrollment.

This article is for general information and is not medical advice. Talk with your health care provider about which vaccines are right for you.

Sources: News-Medical / UT Southwestern Medical Center; National Council on Aging.